Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1444712986
总结
CYP2D6 *1/*4 is not associated with decreased event-free survival, overall survival and Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1.